Objective: Deep vein thrombosis and pulmonary embolism–together referred to as venous
thromboembolism (VTE)–result in a major burden on healthcare systems. However, to the …

Background Venous thromboembolism (VTE) is the second most common medical
complication and a cause of excess length of hospital stay. Its incidence and economic …

Annual costs for venous thromboembolism (VTE) have been defined within the United
States (US) demonstrating a large opportunity for cost savings. Costs for the European …

Healthcare reform is upon the United States (US) healthcare system. Prioritisation of
preventative efforts will guide necessary transitions within the US healthcare system. While …

Systematic cost-effectiveness analyses of regimens used for preventing venous
thromboembolism (VTE) are becoming increasingly important for several reasons: the aging …

Venous thromboembolism (VTE), which includes deep vein thrombosis and pulmonary
embolism, is an important cause of preventable mortality and morbidity. In this study, we …

Costs of Venous Thromboembolism Associated with Hospitalization for Medical Illness - PMC
Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …

BACKGROUND Venous thromboembolism (VTE) is a frequent and potentially costly
complication of major orthopedic surgery. OBJECTIVE To estimate the economic …

Abstract Background: Venous thromboembolism (VTE), which includes deep vein
thrombosis and pulmonary embolism (PE), is a major cause of morbidity and mortality. VTE …

Background We estimated medical costs attributable to venous thromboembolism (VTE)
among patients currently or recently hospitalized for major operation. Methods Using …